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Abstract
Postoperative pain is a commonly discussed topic in patients undergoing anesthesia for
cardiac and thoracic surgery. Uncontrolled or poorly treated postoperative pain has been
studied to cause poor outcomes in patients. Prolonged pain experienced by the patient can
increase the risk of infection, respiratory compromise, development of chronic pain, and
death. Current studies look at multiple modalities of treatment of postoperative pain,
however, a long acting drug that is often under looked and underused is methadone.
Methadone has a prolonged effect that can provide analgesia for an extended period of
time. ). The purpose of this paper is to conduct a systematic review to determine if
intraoperative methadone administration will affect postoperative pain after
cardiothoracic and thoracic surgery as evidenced by pain score levels and documented
postoperative opioid use. This systematic review was created using guidelines put forth
by both PRISMA and CONSORT. A literature review was performed, and data was
gathered from each study. A cross study analysis was performed using data collection
tables designed by the author of this systematic review. Methadone was found to have a
prolonged effect, but evidence was inconclusive due to many limitations by each of the
studies. It is suggested that methadone should be further evaluated in additional
systematic reviews.
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Background/Statement of the Problem
Surgery is one of the most predictable and common sources of pain in
hospitalized patients and is an expected outcome for patients undergoing some type of
surgical intervention or procedure. Incisions through layers of tissue and muscle, along
with the trauma of the surgical procedure itself can cause a variety in intensity of pain in
the surgical setting. In 2010, the performance of 48.3 million surgical and nonsurgical
procedures were recorded as visits to both ambulatory surgical centers and hospitals
(Hall, Schwartzman, Zhang & Liu, 2017). It is estimated that in over 80% of surgical
patients within the United States, postoperative pain is not sufficiently managed (Gan,
2017). While this statistic widely varies with type of surgical procedure, the medications
and anesthetics used intra-operatively and postoperatively, complications, and time
elapsed after surgery, the results remain significant (Gan, 2017). Poorly controlled
postoperative pain in the acute stages increase morbidity risk, impair functional and
quality of life, delay recovery time, increase health care cost, and increase the duration of
opioid usage (Gan, 2017). The presence and high intensity of acute pain in the postsurgical setting highly correlates with the development of chronic pain (Gan, 2017).
Furthermore, the development of chronic pain contributes to disability, interferes with
routine activities and employment, further increases healthcare spending, reduces quality
of life and can contribute to mortality.
Multiple modalities of pain management can be offered by providers, but
preference to certain drugs can impact the provider’s choice of management, rather than
patient specific considerations. A provider’s lack of understanding regarding
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pathophysiology of pain, or the pharmacodynamics of the large variety of drugs can limit
options considered for pain management. This practice potentially excludes the use of
medications that have properties that would allow for the most optimal patient outcomes.
The standard of care for pain management in the acute postoperative phase is still opioid
prescriptions (Gan, 2017).
The Joint Commission is an organization involved in accreditation of healthcare
organizations with the aim to continuously improve the quality and safety of care that is
provided to the public (The Joint Commission, 2018). The commission evaluates aspects
of healthcare and creates standards and goals in which healthcare providers are urged to
follow to support performance improvements in health care organizations throughout The
United States. In 2001, The Joint Commission noted the underassessment and
undertreatment of pain and introduced standards for providers to appropriately monitor,
document and treat pain (The Joint Commission, 2017). In addition to these standards,
The American Society of Anesthesiologists (ASA) developed guidelines to assist
providers in selecting pain management options in the perioperative phase, however,
nationwide protocols are not in place for types of procedures, with regard to specific type
of pain management techniques (The American Society of Anesthesiologists, 2012).
Since surgical patients may range in age, comorbidities, pain tolerance, allergies, and
medication side effects, and more, standards are difficult to develop in offering providers
a protocol to follow while managing pain, especially in the postoperative period.
Additionally, anesthetic management throughout the perioperative period is typically
patient specific and individualized to patient needs. Furthermore, with recent issues
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surrounding the opioid epidemic and abuse of prescription drugs in the United States,
providers are left confused and less willing to write prescriptions that would offer
adequate pain management, fearing abuse and addiction (The Joint Commission, 2017).
One drug in the method of pain management that is typically overlooked is the
use of methadone. Methadone is a synthetic opioid with similar properties to morphine. It
has a much longer duration of action, which ranges widely among individuals, which
could allow for improvement of pain management in the postoperative phase. It is
commonly noted as one of the main drugs of choice for treatment of drug dependence
and is often overlooked in pain management in the perioperative setting (Kharasch,
2011). The purpose of this paper is to conduct a systematic review to determine if
intraoperative methadone administration will affect postoperative pain after
cardiothoracic and thoracic surgery as evidenced by pain score levels and documented
postoperative opioid use.
Next, a review of the literature will be presented.
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Literature Review
An extensive search of literature was performed using the following databases:
CINAHL, PubMed, Ovid, Medline Plus and Cochrane Library. The search was limited to
articles by the following factors: published in the English language from 1990 throughout
the current year and those applicable to subject topic. Search terms included: “pain,” “pain
management,” “cardiothoracic surgery,” “cardiac surgery,” “thoracic surgery,”
“methadone,” “postoperative pain,” “acute pain,” and “chronic pain.”
Pain Definition and Etiology
Defined by The International Association for the Study of Pain (IASP), pain is
defined as “an unpleasant sensory and emotional experience associated with actual or
potential tissue damage or described in terms of such damage” (IASP, 2017). While pain
is typically evaluated as a negative experience, it has had a positive impact on the human
species. Often, pain can indicate certain health issues, such as disruption in normal organ
function, injury, infection or cancerous lesion.
One of the most commonly known causes of pain is related to surgical procedures
or medical interventions. The perioperative phase involves all phases of surgery,
including preoperative and postoperative. Pain can occur in all of these phases. Patients
may experience pain in the preoperative period, otherwise known as the period prior to
surgery, which can be related or unrelated to their planned procedure. During the
intraoperative phase, or the time the patient is being treated within the operating room,
patients are exposed to many types of painful stimuli, such as initial incision or
uncomfortable positioning required to complete the planned procedure. Lastly, the most
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common occurrence of pain in the perioperative setting is postoperatively, or the period
of time after the surgery and during the patient’s period of recovery. In addition to an
unpleasant sensation, pain throughout the entire perioperative phase can contribute to
negative effects on patient’s health and recovery, including prolonged hospital stays,
which can further lead to increased co-morbidities and complications (Hutchinson, 2007).
The etiology of pain is rather complex but can be simplified into an overall
neurological-sensing pathway. Disruptions in normal tissue integrity caused by
mechanical, thermal or chemical means cause nociceptive neurons to increase the rate of
discharge and send signals to the brain for the body to recognize the sensation of pain
(Carr & Goudas, 1999). Depending on the type and degree of pain, nociceptors can have
different responses and the rate of discharge based on the stimulus intensity (Carr &
Goudas, 1999). In a state of tissue destruction and the activation of nociceptors, the body
emits a local inflammatory, immune and mediated cell responses (Car & Goudas, 1999).
Nociceptive information is then conveyed from the site of pain to the dorsal horn of the
spinal cord and through the thalamic, limbic, and cortical structures that are accountable
for the perception of the affective and discriminative responses to the body (Carr &
Goudas, 1999).
Acute pain is a type of pain that is often experienced in the perioperative phases.
It is defined as pain that is short in duration and serves the purpose of warning of illness
or injury, hence stimulating the sympathetic nervous system to elicit the “fight or flight”
response (Helms & Barone, 2008). This response includes increased heart rate and
respiratory rate, apprehension, restlessness, sweating and dilated pupils; symptoms that
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can be recognized and objectively measured by providers in operative patients (Helms &
Barone, 2008). Different subsets of acute pain include somatic, visceral and referred.
Somatic pain is related to pain elicited at, or near skin or subcutaneous tissues, visceral
pertains to the internal organs, and referred pain is pain that is felt in an area distant from
the stimulus site (Helms & Barone, 2008). Diseases, injury, trauma and surgical incisions
can elicit all three of these types of acute pain.
Postoperative Pain
Postoperative pain is pain that is felt after a surgical procedure or intervention and
varies greatly among patients. Acute pain in the immediate post-surgical setting is
typically due to the activation of nociceptors, inflammatory mechanisms, and possible
nerve injury (Kehlet, Jensen & Woolf, 2006). For this reason, in the initial phases, pain is
often described by patients as a spontaneous throbbing or discomfort while resting, in
addition to breakthrough pain at the surgical site and surrounding tissues after pain
medication has been administered (Kehlet et al., 2006). Movement to the affected
surgical location, touching, breathing, coughing, and poor gastrointestinal mobility after
surgery, are further factors that can evoke or increase the pain experience (Kehlet, et al.,
2006).
Despite the increasing awareness of pain and the many guidelines set forth to
manage postoperative pain, it still remains a major challenge in patients who undergo
surgical procedures. According to The Institute of Medicine (2011), approximately 60%
of surgical procedures within the United States are performed within outpatient settings
and patients are discharged to home the same day. In this population, adequate pain
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assessments may not be accurately assessed. Patients are likely to be discharged to home
with lingering anesthetics, opioids or regional nerve blocks, and may not experience a
high level of postoperative pain upon discharge, in comparison to the amount of pain they
may feel once they are at home, hours later. Inadequate pain management, or poor choice
in pain management strategy, can have a large impact on reported pain after surgery. In
addition, patients may not comply with pain regimen, may not understand the education
they received regarding treatment of pain, or be fearful to take opioids causing inadequate
pain relief, or on the contrary, inappropriately self-manage prescription drug dosages or
scheduling (Jafra & Mitra, 2018).
Postoperative Pain Evaluation. Apfelbaum, Chen, Mehta and Gan (2003)
hypothesized that although pain is a common experience following surgery, it is
inadequately managed in most surgical populations. They further emphasized that
postoperative pain has profound consequences on patient’s health and recovery. In a
survey of 250 post-surgical patients, Apfelbaum, et al., (2003) found that 80% of
respondents that had any type of surgery in the past five years reported acute pain after a
variety of surgical procedures, ranging from those performed within hospital inpatient,
outpatient, physician office or outpatient surgical centers. Of this 80% reporting acute
pain, 75% further reported pain after they had been discharged, in comparison to 58% of
patients who reported pain prior to discharge (Apfelbaum et al., 2003). The study also
reported that 59% of patients expressed their primary concern for surgery was the
experience of postoperative pain, and 8% postponed their procedures due to fear of
postoperative pain (Apfelbaum et al., 2003).

8

In a study conducted by Zheng et al. (2017), 890 patients were evaluated after
orthopedic surgery with regard to the impact on postoperative pain and compared
variables such as age, sex, preoperative chronic pain and anesthetic technique. The
authors found the most significant differences in postoperative pain reporting were in
patients who were older than 50 years, female, or those with preoperative chronic pain.
The researchers used questionnaires to inquire about postoperative pain intensity,
interference of pain with activities and feelings, side effects of medications administered,
and the satisfaction of the care received (Zheng et al., 2017). Zheng at al. (2017) found
that the mean amount of time spent in severe pain was 30%, and women reported a
longer period of time in severe pain than men (p < 0.001). All patients reported that their
postoperative pain interfered with physical activities, and on the numerical rating scale
(NRS) evaluating anxiety and helplessness, all patients reported an increased anxiety
level of 2.40 ± 2.46, related to their pain (Zheng et al., 2017). In addition, all patients
reported the feeling of helplessness due to pain at 2.68 ± 2.87 on the NRS (Zheng et al.,
2017).
Zheng et al. (2017), found that the mean postoperative opioid consumption in all
patients was 0.346 mg/kg (± 0.456) morphine equivalents (ME), with women using more
opioids than men. Female consumption was measured at 0.39 mg/kg ± 0.50 (ME) and
male was 0.31 mg/kg ± 0.41(ME) (Zheng et al., 2017). Despite the increased
consumption of opioids in women, both gender groups reported the mean amount of pain
relief was 62% (± 27%), and Zheng et al. (2017) inferred that sex differences did not
show significance in pain intensity ratings. Age was also evaluated in two groups and
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compared by participants under the age of 50 to those over the age of 50. Analysis of
these groups showed that the older age group of women received a significantly reduced
amount of pain relief compared to men (p = 0.040). In contrast, the younger age group of
women experienced a higher amount of pain relief than compared to the men (p = 0.025).
Zheng et al. (2017) reported 17.7% of all patients included in the study stated they would
have preferred to receive better pain management. The mean satisfaction among all the
patients in the study was 7.57 (± 2.77) on a numerical rating scale 0-10 (Zheng et al.,
2017).
Although pain is an anticipated experience after surgery, it is also a highly feared
sensation and can impede patients from seeking surgical treatments. In the two studies by
Zheng et al., (2017) and Apfelbaum et al. (2003), pain is highlighted as a serious
condition that can greatly interfere with patient’s well-being, satisfaction and even
contribute to chronic pain syndromes. It is important to trend factors, such as age, gender,
preoperative pain, amount of opioid administered, and postoperative pain scores, in order
to understand and formulate effective treatment strategies.
Measurement of Postoperative Pain. Pain is considered a subjective sensation
and patients self-reporting of pain is one of the primary considerations in the plan of care.
Pain intensity measurements are a prerequisite in the decision of treatment modalities for
proper pain management (Nagelhout & Plaus, 2014). Reporting scales, such as the visual
analog scale (VAS) and the numerical rating scale (NRS) assess level of pain and are
clinically relevant in measuring pain intensity (Nagelhout & Plaus, 2014). Each scale
uses the goal to allow the patient to assign a value to level of pain they are experiencing.
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This information can be used to direct the provider in formulating the most effective type
of treatment and dose.
Visual Analog Scale. The VAS is a continuous scale consisting of 100mm
vertical or horizontal lines with extremes labeled as worst imaginable pain and zero pain
(Kliger et al., 2014). Patients are instructed to mark the intensity of the pain being felt on
a line between the two extremes. This option allows providers to monitor the amount of
pain the patient is experiencing, and plan strategies based on that exam. The VAS does
not require the patient to have verbal or reading skills and is versatile and can be used in a
wide variety of settings (Kliger et al., 2014). Disadvantages of this scale include the
requirement of visual acuity and the patient’s ability to convert pain experience to an
abstract scale (Kliger et al., 2014). For these reasons, it has been reported the VAS has a
failure rate of 7-16%, especially in elderly, young children, handicapped and mentally
challenged populations of patients (Kliger et al., 2014).
Numeric Rating Scale. Similar to the VAS, the NRS is an 11-point scale that
patients use to provide a value from 0-10 regarding the intensity of their pain. A score of
0 indicates no pain and a score of 10 indicated the worst imaginable pain (van Dijk,
Kappen, Schuurmans, & van Wijck, 2014). The VAS and NRS are very similar in
approach to acquiring pain score from an individual, although the VAS has a visual key
that can be utilized by the patient to point to, rather than the NRS in which patients
typically assign a number to their pain without the use of visual aids. Therefore, these
two scales have similar advantages and disadvantages. The ease of the NRS, and lack of
visual requirements make this assessment technique more popular in the clinical setting.
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In addition, pain management strategies are often prescribed based on the NRS value the
patient reports. Providers may write prescriptions for certain medications or opioids for
pain management if the NRS level is above 3 or 4, with incremental dosage increase,
depending on patient NRS score (van Dijk et al., 2014).
Disadvantages. Both pain scales typically lack consideration of patient age or
cognitive level, in which developmental function may influence pain scores (Nagelhout
& Plaus, 2014). Additionally, they lack depth of determining the quality of the pain and
other possible exacerbating or associated factors that could affect pain (Nagelhout &
Plaus, 2014). Patient understanding of rating pain on the scale is crucial, and may be
influenced by patient culture, pain history, or tolerance to pain.
Postoperative Pain after Thoracic Surgery. Thoracic surgery is inclusive of
surgical procedures involving the thoracic cage, and can include: airway, esophagus,
lungs, diaphragm, chest wall, and heart. A wide variety of factors cause pain after
thoracic surgery, including: tissue retraction, vein harvesting, artery dissection, along
with prolonged surgery and sustained uncomfortable position throughout the procedure
(Bignami et al., 2018). In addition, inflammation of tissue triggered by the trauma
induced by intended surgical bone fractures and dislocations can create a significant
amount of pain (Bignami et al., 2018). Along with the multiple painful factors of surgery
itself, patients typically leave the operating room with drainage catheters, sternotomy
and/or thoracotomy incisions, central venous access devices and more, which can have a
large impact on pain scores (Bignami et al., 2018).
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Reported postoperative pain following thoracic surgery is often higher in the first
two days after surgery and typically reported as more intense in young, female
populations (Bignami et al., 2018). Multiple guidelines support positive patient outcomes
when patients participate in early ambulation and advance diets within hours to a day
after the surgical procedure (Sarin et al., 2016). Coughing, deep breathing, eating and
increasing activity level can contribute to pain and result in patient apprehension to
continue activity, but can speed overall recovery rates, lessen duration of pain and
minimize its consequences (Sarin et al., 2016).
Studies of postoperative pain after thoracic surgery. Guastella et al. (2011)
conducted a prospective study of 54 patients to evaluate pain following thoracic surgery.
The study evaluated patients that underwent a thoracotomy with a single surgical team
using standardized approaches for the surgery and analgesic management. The population
reported NRS scores < 3 in the first 72 hours after surgery when using a pain regimen
protocol. Two months after surgery, 49 patients (91%) reported continued thoracic pain
and of those, 12 patients were still using analgesics. At 6 months, 7 patients were
excluded from the study due to lack of follow up, and 38 of 42, or 90.4%, of patients
reported persistent postoperative pain. 30.9% of those patients reported still using
analgesics, and 2 patients transitioned to antidepressants for pain management (Guastella
et al., 2011). At the six-month evaluation, three patients were additionally lost in follow
up due to difficulties in correctly evaluating pain, leaving a total of 35 patients remaining
for further evaluation for chronic postoperative pain. Of this group of patients, the mean
NRS score was 3.93 ± 2.3, and of the 13 patients still utilizing pain treatment, NRS was
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6.16 ± 2.1. Spontaneous pain at incision or surgical area was reported by 86% of patients,
most commonly referred to as throbbing, shock-like and wrenching pain (Guastella et al.,
2011).
In a prospective observational study by Wang et al., (2017), 300 patients were
evaluated for pain intensity following thoracic surgery in the immediate first seven days
of surgery and then in intervals, up to 6 months after surgery. The study reported that in
the first 2 days after surgery, using the NRS, approximately 65% of patients reported
moderate to severe pain with movement, which decreased to 30% of patients by
postoperative days (PTD) 4-7 (Wang et al., 2017). Pain intensity with coughing was also
reported as moderate to severe in 85% of patients PTD 1-2, with a decrease in 65% of
moderate to severe by PTD 4-7 (Wang et al., 2017). In patients reevaluated at six months
after their surgery, 48.9% reported continued, chronic pain (Wang et al., 2017). The
authors also concluded that patients were more reluctant to request pain management
when desired, especially if not properly educated regarding the importance of pain
management or were not aggressive in treating pain before severe levels occurred (Wang
et al., 2017).
Pharmacological Options
Current clinical guidelines for the management of postoperative pain have evolved
over recent years in response to the reported high levels of pain after surgical procedures.
In the past few decades, providers have relied heavily on the use of medications that hold
a shorter half-life, thus providing a shorter duration of action (Kharasch, 2011). This can
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lead to uncontrolled pain after surgery, which may become difficult to manage once it
escalates to a higher level.
With input from the American Society of Anesthesiologists (ASA), The American
Pain Society created an interdisciplinary panel of experts in pain management to decipher
and promote evidenced based, safe, postoperative pain management in adults and
children (Chou et al., 2016). As part of the guideline process, the expert panel review
conducted a systematic review, including a review of the literature to evaluate different
aspects of pain management in relation to various interventions and management
strategies of postoperative pain. Chou et al., (2016) formulated recommendations based
on their findings that addressed different aspects of postoperative pain. The
recommendations include: preoperative patient education, perioperative pain
management techniques and planning, multimodal approach of pharmacological and
nonpharmacological treatment modalities, organizational policies and the transition of
patient care to an outpatient setting (Chou et al., 2016). The foundation of optimal
postoperative pain management includes the premise that treatment of postoperative pain
is initiated in the preoperative phase with patient centered assessments, and plan that
focuses on the individual and proposed surgical procedure (Chou et al., 2016).
Patient Controlled Analgesia. Patient controlled analgesia (PCA) is widely used in
postoperative management of pain. The use of this method allows for patients to press a
button, programmed by a pump, and the patient is able to deliver a dose of pain
medication when they feel pain and wish to seek relief. PCA pumps are programmed by
the provider and control parameters are set, including bolus dose, lockout interval, dose
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limits and loading dose of the medication upon establishment of the pump (Kuo, Chang,
Juan, Hsu, Chan & Tsou, 2018). If deemed necessary, the provider can also program the
PCA to deliver a continuous infusion of the opioid in addition to the controlled doses the
patient can receive. The PCA maintains a log of records of all events pertaining to the
therapy, including amount of patient demand and amount of opioid delivered over a
period of time. Patients utilize the PCA in the first few hours or days after surgery and are
commonly switched to oral pain medication. Although a highly effective method of
providing pain relief after surgery, it also carries risks, including: respiratory depression,
respiratory arrest or even death, if not properly and closely monitored (Kharasch, 2011).
Neuraxial Analgesia. Central neuraxial anesthesia is the placement of anesthetic
solution onto, or adjacent to, the spinal cord, and includes spinal and epidural anesthesia
(Nagelhout & Plaus, 2014). Due to the location of the desired sensory blockade in
thoracic surgery, spinal injections are contraindicated, but epidurals can be utilized
(Nagelhout & Plaus, 2014). An epidural injection can be performed with an attached
catheter that can be used for multiple doses of anesthetics or pain medication, throughout
a procedure, and later in the postoperative phase (Nagelhout & Plaus, 2014). Multiple
advantages of epidural catheters exist, such as allowing the patient to use a patient
controlled epidural analgesia (PCEA) to deliver medications by the epidural catheter and
decreased risk of: venous thrombosis, myocardial infarction, respiratory depression and
pneumonia (Chou et al., 2016).
Chou et al. (2016) further found that in the treatment of thoracic perioperative
pain, current guidelines recommend neuraxial analgesia, such as epidural anesthesia,
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especially for patients at risk for pulmonary or cardiac complications. Chou et al. (2016)
suggested that neuraxial analgesia with local anesthetics, is associated with decreased
requirements for acute pain management, also referred by rescue analgesia.
Comparison. In a meta-analysis of randomized control trials conducted by Wu et
al., (2005) PCEA provided significantly superior postoperative pain control compared to
PCA, for up to three days after surgery. The meta-analysis included 50 articles that
compared the use of PCA versus PCEA for pain control in postoperative pain
management (Wu et al., 2005). The study then compared the type of surgery and pain
scores. According to Wu et al. (2005), average pain scores for patients with a PCEA were
1.6 ± 1.5 of 1,157 patients, compared to PCA scores 2.7 ± 1.8 in 1,139 patients. The
authors concluded that due to the ability of PCEA management to block nociceptive input
to the central nervous system with the addition of opioids, compared to intravenous
administration allowed for greater pain control (Wu et al., 2005). Unfortunately,
neuraxial anesthesia is not always an option due to patient refusal, inadequate provider
skill, unsuccessful insertion attempts, or other technical or medical reasons. A few of the
main contraindications of neuraxial anesthesia include mitral or aortic stenosis and
preoperative anticoagulation regimens, which are both highly typical of a patient
planning to undergo cardiothoracic surgery (Nagelhout & Plaus, 2014).
Oral and Intravenous Opioids. Systemic analgesics and adjunctive medications
are the main alternative to invasive techniques and continue as the main approach for
pain management following intraoperative procedures (Gottschalk, Cohen, Yang &
Ochroch, 2006). Opioids are still currently the main option for treatment of pain in all
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phases of surgery, especially in the postoperative phase. Intravenous administration is
typically utilized intraoperatively and then converted to oral administration once the
patient is able to eat and drink fluids. Unfortunately, opioids carry a significant risk of
causing dependence, addiction and respiratory depression, especially in higher doses. To
prevent these side effects, adjuvant medications, such as Nonsteroidal Anti-inflammatory
Drugs (NSAIDs), acetaminophen, gabapentin and tramadol are often considered
(Gottschalk et al., 2006).
Consequences of Postoperative Pain
Extended periods of postoperative pain can have significant consequences to
patient’s health and recovery physiologically and psychologically. In the initial
postoperative phase, pain is considered acute, but if prolonged, it can become chronic
pain.
Acute Postoperative Pain. Extended periods of unrelieved pain can cause a
negative effect on every major organ within the human body. With regard to the
endocrine system, pituitary-adrenal activation can occur and lead to impaired
immunological function and increase the risk of postoperative wound infection
(Hutchinson, 2007). This infection risk is noted as even higher than original surgical risk
of infection (Hutchinson, 2007). Pain can increase sympathetic response that can cause
negative effects to the cardiovascular, renal and gastrointestinal systems, which lead to
vasoconstriction and reduced blood flow to vital organs. In addition, pain can cause
patient apprehension related to ambulation, deep breathing exercises, nutrition, which are
often important elements in recovery of the surgical patient (Hutchinson, 2007).
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Patients that receive adequate pain management enhance their ability to
participate in early mobility, and thus lessen the risks of urinary retention, ileus, and
myocardial infarction (Glowacki, 2015). In addition, with proper pain management, sleep
deprivation which can later lead to postoperative fatigue and delirium, can be avoided.
Prevention of postoperative fatigue can also enhance mobility after surgery, and reduce
the amount of pulmonary complications (Glowacki, 2015).
Adverse Complications. As a result of the multiple complications listed, a wide
range of potential adverse events can occur, such as deep vein thrombosis, pneumonia,
wound infection, pulmonary embolism, myocardial infarction, and chronic pain
syndrome (Hutchinson, 2007). Prolonged illnesses or complications can lead to mental
health issues such as stress, depression, and anxiety (Hutchinson, 2007). Furthermore,
beyond the medical issues, poor pain management can contribute to increased healthcare
costs for the patient and provider. Prolonged hospital courses, readmissions and patient
dissatisfaction are also factors that add to poor outcomes after surgery (Hutchinson,
2007).
According to Glowacki (2015), five dimensions contribute to pain management:
physiological, sensory, affective, cognitive, and sociocultural components. Each
dimension is crucial for patient evaluation with regard to management of acute pain.
Aggressive pain control in the acute phases is still an underutilized technique, and despite
guidelines and studies published to evaluate pain management, patients are still left
somewhat unsatisfied. Glowacki (2015) infers that if all five dimensions of pain
management are addressed, adverse complications of acute pain can be avoided.
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Chronic Postoperative Pain. According to the International Association for the
Study of Pain (2002), chronic pain is defined as pain that recurs or persists within range
beyond the healed incision site, at least two months after the surgical procedure. This
pain can lead to immobility of surgical site and surrounding areas due to exacerbation of
pain. Patients with suboptimal pain management in the acute phase after surgery are at
risk of developing persistent pain which can then progress to chronic pain. This can lead
to further and increased opioid requirements, tolerance and possible opioid addiction.
Chronic Pain Following Cardiac Surgery. In a prospective cohort study by van
Gulik et al. (2011), 146 patients were evaluated following cardiac surgery via
sternotomy. In all patients, anesthesia was standardized during induction and
maintenance phases of the anesthetic approach. Pain was managed in the postoperative
phase of surgery with a continuous infusion of morphine, in combination with
acetaminophen (Gulik et al., 2011). Pain scores were evaluated during the initial seven
days following the surgery and 10-12 months after the surgery by telephone interview by
questionnaire and evaluation of NRS score. At 10-12 months following the surgery, 35%
reported the sensation of chronic thoracic pain and 29.2% reported severe pain (Gulik et
al., 2011). Additionally, regardless of type of thoracic procedure, such as Coronary
Artery Bypass Graft (CABG), valve surgery, aortic and CABG combined with valve
surgery, the incidence of chronic pain was the same among each surgery (van Gulik et al.,
2011). Of the chronic pain sufferers, 14.3% reported minor or major pain that had
influence on their daily life and had to stop working or reduce their work hours due to the
pain (van Gulik et al., 2011). Van Gulik et al. (2011) did not find a difference in chronic
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pain scores of those patients that had previously undergone a sternotomy prior to the
surgery being evaluated. Van Gulik et al. (2011) determined that several characteristics
correlated with the development of chronic pain one year after cardiac surgery. These
characteristics included: non-elective surgery, resternotomy shortly after the original
surgery, female gender and severe pain on the third postoperative day (Gulik et al., 2011).
A prospective study conducted by Bayman, Parekh, Keech, Selte, and Brennan
(2017) evaluated 99 patients at 3 and 6 months after thoracic surgery to evaluate for
chronic pain. Two surgical methods were compared: thoracotomy and video assisted
thorascopic surgery (VATS). Researchers found that chronic pain values measured at 3
and 6 months postoperatively by use of the NRS were similar among the two. The goal of
the study was to detect predictors of chronic pain and to determine if acute pain played a
significant role in the development of postoperative chronic pain. In the immediate
postoperative phase, pain was managed with patient-controlled analgesia and measured in
morphine equivalents. Researchers evaluated NRS scores in the first three days after
surgery, in addition to the presence and amount of chest tubes each patient had. There
were no differences in the average NRS in the preoperative or 3-day postoperative phase
in either surgical groups. Bayman et al. (2017), found that the incidence of chronic pain
in their study at 3 months after either surgery was prevalent in 34% of patients, and at 6
months, was 27%. At 3 months, 16% of patients reported pain that limited daily
activities, and at 6 months, 8.2% reported continued limitations (Bayman et al., 2017).
The study linked the incidence of a higher severity of pain during the first three days
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postoperatively to a higher incidence of chronic pain lasting 6 months after the initial
surgery.
Methadone
Methadone was introduced in 1940 as a synthetic opioid and contains the same
potency and similar side effects as morphine when given intravenously (Barbosa Neto, et
al., 2014). A close relationship between stereochemical structure and potency of opioids
exists between naturally occurring morphine and synthetic methadone (Nagelhout &
Plaus, 2014). Methadone is considered a diphenylheptane derivative and holds a slightly
similar molecular structure to morphine, comprised of two of the five natural ring
structures seen in morphine (Nagelhout & Plaus, 2014). Methadone and morphine both
affect the same pain receptors, mu, kappa and delta (Nagelhout & Plaus, 2014).
Structurally, methadone is a racemic mixture of d-isomer (S-methadone) and l-isomer (Rmethadone), which each component allowing for a different mechanism of pain control
(Nagelhout & Plaus, 2014). The d-isomer allows antagonization of the NMDA receptor,
inhibiting uptake of norepinephrine and serotonin, which contributes to treatment of
neuropathic pain and prevention of opioid tolerance (Nagelhout & Plaus, 2014). The lisomer binds to opioid receptors, therefore treating pain (Nagelhout & Plaus, 2014).
Methadone can be administered via oral, intravenous, subcutaneous, and rectal route
(Nagelhout & Plaus, 2014). When administered orally, methadone’s peak effect is 30-60
minutes, and intravenously, effects are seen within 15-20 minutes (Nagelhout & Plaus,
2014).
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In current practice, methadone is primarily used for treatment of chronic pain,
opioid abstinence syndrome, and treatment of heroin addiction (Nagelhout & Plaus,
2014). As compared to other opioids, it produces less euphoria and has a longer half-life,
which allows for less frequent dosing requirements (Nagelhout & Plaus, 2014). The
elimination half-life, referred by the amount of time for half of the drug to be eliminated
from the body, can range greatly among individuals, from 8-90 hours (Barbosa Neto, et
al., 2014). This allows an extended period of duration of action from 4-8 hours (Barbosa
Neto, et al., 2014). The prolongation of the drug and drug effect is partly due to the
extensive protein binding it has within the body, which allows for a slow release and
delayed metabolization of the drug (Nagelhout & Plaus, 2014). In addition, methadone
has a high bioavailability and is not associated with active metabolites (Nagelhout &
Plaus, 2014).
Methadone: Role in Postoperative Pain Management
Multilevel Thoracolumbar Spine Surgery. The use of methadone in the surgical
population has been widely studied in various types of surgeries, such as spinal surgery
and total hip arthroplasty. In recent studies, methadone has been compared to other,
shorter acting drugs and evaluated for efficacy and pain control in the postoperative
phase. In a randomized control trial conducted by Gottschalk, Durieux, and Nemergut
(2011), a single dose of intraoperative methadone was compared to a continuous infusion
of sufentanil, a short acting opioid, in patients undergoing lumbar spinal surgery. The
population included 29 patients that underwent multilevel thoracolumbar spine surgery.
Pain was reassessed at 24, 48, and 72 hours after surgery (Gottschalk et al., 2011).
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Patient demographics in each of the groups were similar with respect to age, sex, body
weight and height, body mass index and American Society of Anesthesiologists (ASA)
status.
Gottschalk et al., (2011), found that the preoperative opioid use, preoperative pain
scores, length of surgery, time to extubation, estimated blood loss, and intraoperative
crystalloid or colloid requirements were comparable between both groups. Pain after
surgery was reported to be significantly less and more statistically significant 48 hours
after extubation in the methadone group. To effectively compare the two medications,
dosages were converted to morphine equivalents. In the sufentanil versus methadone
group, at 48 hours postoperative, morphine equivalents were measured at 63mg versus 25
mg, and at 72 hours after surgery 34 mg versus 15 mg (Gottschalk et al., 2011). In
addition to these findings, the study proved that pain scores were approximately 50%
lower in the methadone group versus the sufentanil group at 48 hours after surgery
(Gottschalk et al., 2011). Gottschalk et al., (2011), inferred that perioperative use of one
single bolus of methadone improves postoperative pain control and allows a reduction of
additional opioid requirements in patients undergoing complex spine surgery.
Pacreau, Candil, Carazo and Galinski (2012) evaluated the intraoperative use of
methadone versus methadone mixed with ketamine on postoperative opioid consumption
in 22 patients undergoing multilevel lumbar arthrodesis. The MK group, methadone
mixed with ketamine, received a pre-incisional bolus of intravenous racemic ketamine
0.5mg/kg, followed by an infusion of 2.5mg/kg/min of methadone. The patients in the
control group, ME group, received a bolus of saline and an infusion of 2.5mg/kg/min of
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methadone. Postoperatively at 24-48 hours, each patient group was given a PCA
administering 1 ml bolus, with a lockout of 10 minutes and maximum of 3 boluses per
hour. In the MK group, the PCA contained 0.25mg of methadone plus 0.5mg of ketamine
and the ME group contained 0.5mg of methadone.
Strict methods and protocols were held for induction of anesthesia and held
throughout the patients’ operative time. Postoperatively, the NRS value was evaluated
and recorded, and 2mg of methadone boluses were administered every 15 minutes until
the NRS scale was equal or less than 3, and then the PCA was started. A blinded team
member recorded the NRS value at rest and at movement, at 24 and 48 hours. Also
recorded was the amount of consumption of opioid delivered, the demanded doses and
the delivery to demand ratio.
Pacreau et al. (2012) found that the difference between the consumption of
methadone at 24 hours by PCA was an average of 15mg for the ME group versus 3.4mg
for the MK group. At mobilization, pain average for MK group was 4.5 and for ME
group 6 on the NRS scale (Pacreau et al., 2012). Pacreau et al. (2012) found that while
methadone is an effective drug for postoperative pain, the use of methadone with an
adjunctive treatment for pain provided a significant level of pain control, as evidenced by
lower pain scores and decreased opioid intake.
Total Hip Arthroplasty. Barbosa Neto et al., (2014) conducted a randomized,
double blind, controlled, parallel group study comparing the pain management of 34
patients that underwent a Total Hip Arthroplasty (THA) and received postoperative
morphine PCA versus methadone PCA. Surgery was performed under spinal anesthesia
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by the same surgical team using similar surgical approaches in each of the groups. Drug
potency ratio was 1:1 to compare and convert total morphine to methadone consumption.
During the postoperative phase, patients were assessed five times to collect information
regarding pain intensity, side effects, and analgesic consumption (Barbosa Neto et al.,
2014). Reassessments of pain were scheduled on arrival to Post-Anesthesia Care Unit
(PACU), and then at 6, 12, 18 and 24 hours after PCA installation (Barbosa Neto et al.,
2014). Based on data collected, it was determined that opioid consumption at 24 hours
postoperative was significantly lower in the methadone group than the morphine (37 mg
of methadone use versus 55.6 mg of morphine) (Barbosa Neto et al., 2014). Barbosa Neto
et al., (2014) concluded that methadone PCA presented as a favorable drug in the
selection of pain management in treating postoperative pain in major surgeries.
Conclusion
Methadone is a drug that is often stigmatized due to its use in the treatment of
substance abuse. Unfortunately, advantageous benefits of the drug are limited in the
surgical setting. Methadone is a drug that can offer substantial pain management in the
postoperative setting for a wide variety of patients. Although methadone can have
varying lengths of duration in individuals, it can offer longer pain management than most
opioids used in current practice. For this reason, it can potentially decrease the amount of
opioid intake and length of time patients are in pain after surgery. As previously noted,
the importance of management of acute postoperative pain can be crucial in preventing
severe side effects, such as: increased length of hospital stay, poor healing, increased
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comorbidities, the development of chronic pain, and much more. Methadone should be
evaluated for its potential use in the surgical setting in cardiac and thoracic surgeries.
Next, the theoretical framework utilized in this systematic review will be discussed.
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Theoretical Framework
Healthcare is rapidly growing and frequently changing practice, based on
evidence-based data. In order to enhance the delivery of healthcare that Certified
Registered Nurse Anesthetists (CRNAs) provide, empirical evidence is examined, proven
and converted to standards and guidelines, and placed into practice. Therefore, extracting
and evaluating the most relevant evidence available in systematic reviews and meta
analyses is required to examine strength and validity. The use of The Preferred
Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement
supports the methods used to search and evaluate the articles used in this systematic
review. The PRISMA guidelines were used to improve the quality of data reporting and
in the assessment of strengths and weaknesses of each article in the review.
The PRISMA statement (Appendix A) consists of an evidence-based checklist of
27 items that are considered crucial for accurately reporting and evaluating a research
study (Daley, 2016). The checklist is divided into categories of sections found in standard
research, including: title, abstract, introduction, methods, data collection processes,
results, and discussion, bias reporting, limitations, with an additional section providing
information regarding funding. After these considerations are met, the articles will then
be further investigated for eligibility and omitted if unable to meet previously established
inclusion and exclusion criteria. The remaining articles will be utilized for data synthesis
and recommendations.
The PRISMA guideline also incorporates a flow diagram that can be used for
additional organization of the literature review. The flow diagram allows for transparency
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regarding article selection of inclusion and exclusion criteria. It also allows for guidance
among reporting information regarding final number of studies utilized throughout the
systematic review. In addition to the PRISMA checklist and flowchart, the consolidated
standards of reporting trials framework (CONSORT) are also used (CONSORT, 2011).
CONSORT was used to further evaluate and determine quality of the randomized control
trials utilized in this systematic review. CONSORT was designed and utilized to assess
randomized control trials to evaluate strengths, weaknesses and any limitations to be
included, in addition to any research bias.
Next, the methods utilized in this systematic review will be discussed.
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Methods
Purpose of Study
The purpose of this paper is to conduct a systematic review to determine if
intraoperative methadone administration will affect postoperative pain after
cardiothoracic and thoracic surgery as evidenced by pain score levels and documented
postoperative opioid use.
Inclusion and Exclusion Criteria
Inclusion criteria will include: randomized control trials pertaining to subjects 18
years or older; studies evaluating the administration of methadone in a cardiac or thoracic
surgery, and evaluation of pain scores postoperatively using pain scales. Exclusion
criteria: research before 2004; non-English articles, non-human subjects, and pain
management articles not related to methadone use.
Search Strategy
The literature search was performed using CINAHL and PubMed databases. The
initial search was generalized and conducted by using the keyword “methadone” within
each database. A total of 5,120 were found utilizing CINAHL and an additional 15,610
articles were located within PubMed. The search was narrowed by the addition of a
second keyword: “surgery.” The results from both CINAHL and PubMed were
drastically reduced to 53 and 542 items, respectively. A final filter was placed to limit the
search of literature between the years 2004 and 2019, specifically related to cardiac or
thoracic surgery, in addition to filtering the articles to those reporting on adult, human
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subjects only, and written in English. The final search resulted in 23 articles from
CINAHL and 80 from PubMed.
Data Collection
Subsequent to the collection of articles, the randomized control trials (RCT) were
reviewed and relevant data was extracted for further analysis. Data was collected from
randomized clinical trials in which methadone was given to a portion of the sample
population during any part of the operative phase, and later compared opioid use from
those who received the methadone versus the control group. As an effort to analyze the
influence of methadone on NRS scores in addition to other variables measured in the
randomized control trials, a table was created for data collection and comparison of each
of the studies. The first table was designed to compare basic, demographic data regarding
the groups of patients studied. This included: author, year, number of patients in the
study, ages of participants, gender, ASA score, procedure performed, duration of
procedure, and allocation of participants into the control and interventional groups (Table
1).

31

Table 1
Data Collection Sheet #1
Author, Year

#Pt

Ages
(yr)

M/F

ASA

Procedure

Duration

methadone

(min)

Group

Control Group

A second table was created to organize study variables that may have a possible
influence over pain scores within each of the trials. Data Collection table # 2 included
author and year, agents used for induction of anesthesia, agents used for the maintenance
of anesthesia, timing of administration of the study drug, intraoperative methadone dose
administered, intraoperative interventional dose administered, rescue pain medication and
dosing used in recovery after surgery, time to first analgesic in each group (Appendix D).
Critical Appraisal
The critical appraisal tool used to evaluate the randomized control trials in this
review was The Consolidated Standards of Reporting Trials, or CONSORT method
(Appendix B). The method is a 25-item checklist, utilized to distinguish strengths,
weaknesses, limitations and biases of each of the trials. This includes trial design,

Route
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participant eligibility and criteria, setting and location of data collection, interventions
administered, outcome measures, sample size determination, randomization, blinding,
and funding.
A flow diagram designed by CONSORT, illustrated in figure 1 on the next page,
was utilized to assess and determine strength and weaknesses of the randomized control
trial. The diagram concentrates on sample size, randomization, allocation of participants
and those participants lost during follow up and analysis. The flow diagram was
completed for each randomized control trial involved in this systematic review.
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Figure 1. CONSORT Flow Diagram (CONSORT, 2010)

34

To best organize the data from the CONSORT findings, a table was created. This
table includes: author and year, study type, consent and funding, inclusion and exclusion
criteria, randomization, attrition, blinding methods, strengths and limitations of each
study (Appendix E). These categories were chosen based on guidelines from both
CONSORT and PRISMA checklists and flow diagrams. This method allowed for a more
concise and valuable assessment tool.
Data Synthesis and Cross Study Analysis
The data collection tools that were utilized to derive information from the
randomized control trials allowed synthesis and analysis of the data comparatively across
each of the studies. A cross study analysis was performed to evaluate the length of
surgical duration, time to extubation, time to when the patient needed their first rescue
analgesic, the overall NRS scores in the first 24 hours, the extended NRS scores if
provided in the study, other and adverse events. The data was transcribed into the table
below (Table 2), and the results later described in this paper.
Table 2
Cross Study Analysis
Author, Surgery Time to
Time to NRS in
Year
Time
extubation 1st
first 24
(hr)
(hr)
rescue
hrs
analgesic
(hr)

NRS
extended
period

Other

Adverse
Events
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Next, the results section will be discussed.
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Results
The PRISMA flow diagram (Appendix E), accompanied by inclusion and
exclusion criteria previously mentioned, were used to eliminate and select applicable
articles appropriate for this systematic review. After the search for applicable articles and
elimination of duplicate articles, a total of 28 articles remained for review. The abstracts
of these articles were evaluated for evidence of exclusion criteria. This process
eliminated a total of 16 articles. The remaining 12 articles were reviewed thoroughly for
their relevance and were selected for the systematic review based on both inclusion and
exclusion criteria. The final elimination process excluded 7 articles, leaving 5 articles for
inclusion in the systematic review. The five remaining articles were randomized control
trials that met the inclusion criteria and were used in the creation of this systematic
review. The following information is a summary of results obtained from the data
collected.
Cardiac Surgery
The randomized control trial conducted by Carvalho, Sebold, Calegari, de
Oliveria and Schuelter-Trevisol (2011), included 104 patients submitted to coronary
bypass graft surgery without cardiopulmonary bypass, age ranging from 53-73 years old
and ASA III-IV. The study reported 63% of patients were males, and additionally
reported no proportional difference between groups regarding sex (p-value 0.534)
(Carvalho et al., 2011). The mean duration of the surgery between the two groups ranged
from 187.2-201.1 minutes, with the methadone group mean slightly longer than the
morphine group. Four participants were excluded, two from each group for reasons of:
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death, prolonged intubation lasting more than 12 hours and reintubation. This changed
the final number of participants to 100. Induction of anesthesia was performed with
sufentanil 0.5 mcg/kg, with 10 mcg boluses as needed, etomidate 0.2mg/kg and
rocuronium 0.1mg/kg. Maintenance of anesthesia was achieved with sufentanil 0.25-0.5
mcg/kg/hr and sevoflurane 0.5-1 MAC. Patients remained intubated at the end of the
procedure upon arrival to ICU. Providers in the ICU were blinded to the group each
patient was assigned to. Patients in both groups were given intravenous dipyrone 1 gram
every six hours continuously. If patient complained of moderate or severe pain,
intravenous morphine 0.03 mg/kg was administered, with a limit of 0.1 mg/kg in a fourhour period. If patient complained of nausea or vomiting, metoclopramide hydrochloride
10 mg was administered. Duration of anesthesia, number of doses and types of analgesics
and antiemetics were recorded during the postoperative time, along with adverse
reactions, such as nausea, vomiting, and respiratory depression. Respiratory depression
was defined as a rate of less than 8 respirations per minute, and/or the requirement of reintubation. These reactions were observed by the ICU professionals and/or research team
throughout the patient’s ICU admission.
Numerical pain scores were recorded at 12, 24 and 36 hours postoperatively. In
addition, blinded researchers recorded the first analgesic administration and extubation
time. The numerical pain scale was used, with ranges of 0-3 considered mild pain, 4-7
moderate pain and 8-10 severe pain. Mean and standard deviation of pain scores were
represented in the study at 12, 24 and 36 hours for both groups. At 12 hours, the
morphine group pain score mean was 4.7 ± 2.6 and methadone was 4.2 ± 2.7. At 24
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hours, morphine scores were 2.9 ± 2.6 and methadone 1.9 ± 2.2, and at 36 hours
morphine 0.5 ± 1.1 and methadone 0.5 ± 1.2. The time to first analgesic in minutes was
269.4 ± 252.9 for the morphine group; the methadone group was shorter, at 149.9 ±
178.5. Although this time was shorter, 43% of the morphine group required additional
postoperative morphine versus 29% of the methadone group. The morphine group had
19% adverse events versus the methadone group at 16%. In addition, 27% of the
morphine group required metoclopramide for nausea or vomiting, versus the 18% of the
methadone group. Respiratory failure in each group was similar, 1% of morphine and 2%
of methadone.
Patients were evaluated for overall satisfaction regarding pain analgesia and
occurrence of adverse events in 36 hours. The morphine group reported a 28% success
rate of satisfaction and the methadone group reported 44% success rate. The study
utilized the Kolmogorov-Smirnov test to analyze quantitative, normally distributed data,
and the Student’s t-test to compare means. In non-normal distribution, non-parametric
statistics were used applying the Wilcoxon-Mann-Whitney U test. The Pearson chi square
test was also used to verify the association between the variables of interest.
Using the CONSORT framework, a flow diagram was presented to assess sample
size, eligibility, exclusion criteria, randomization and attrition of the participants in the
study (Appendix H-1). The study did not measure level of sedation of patients, which
could have had an impact on the patient’s level of pain. In addition, pain score medians
were recorded at 12, 24 and 36 hours, but information regarding amount of patient
assessments, or evaluation of pain scores were not reported. The study also reported
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respiratory failure in each group but did not elaborate on the cause or treatment the
patient received. The study reported three patients were excluded prior to initiation of the
study due to prolonged extubation time and reintubation. It is unclear by the study if it
had an effect on pain scores on either group.
The trial conducted by Udelsman et al. (2011) a group of patients scheduled for
cardiac surgery with cardiac bypass, were divided into three groups and given
methadone, morphine or a placebo, at induction of anesthesia. The study included 55
patients, ages ranging from 42-72, and ASA III-IV. The study excluded patients on
antidepressants, known allergy to study drugs, chronic opioid use, and patients that
remained intubated longer than 24 hours after surgery. Information regarding initial pool
of patients nor details about the number, nor reason for exclusion of patients was
included. Patients were randomly and double blinded into three groups: methadone,
morphine and control. Induction on all three groups was performed with sufentanil 0.1
mcg/kg, midazolam 0.1 mg/kg and pancuronium 0.1 mg/kg. After induction, each blinded
group received a dose of either 20 mg of morphine, 20 mg of methadone or 2 mL of
normal saline. Anesthesia was maintained with sufentanil 0.01 mcg/kg/min, isoflurane
0.5% and when clinically indicated, pancuronium 0.03 mg/kg. Patients were transferred
to the intensive care unit and continually monitored for pain. After extubation, morphine
0.03 mg/kg was administered throughout the postoperative period when necessary.
The study evaluated duration of anesthesia, time until extubation, time until
administration of the first dose of analgesic, number of doses of analgesics required and
prevalence of nausea or vomiting. Time to extubation for each group were as follows:
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methadone 430.83 +/ 304.35, morphine 358.95 ± 179.15 and control 341.67 ± 144.41. In
addition, the time to first analgesic for each group were as follows: methadone 855.17 ±
593.39, morphine 625.53 ± 525.23 and control 507.56 ± 413.04. The study reported the
number of patients requiring analgesics in the first 24 hours was lowest in the methadone
group and significantly higher in the control group. Patients requiring analgesic in the
first 24 hours was reported in 10 of 18 patients in the methadone group, with a median
NRS score of 0.5 ± 0.71. The authors of this study reported the number of required doses
of pain medication were 0.89 ± 1.02. Comparatively, 14 of the 19 patients in the
morphine group required 1.32 ± 1.05 doses with a median NRS of 1.84 ± 1.38. The
control group required 2.39 ± 0.85 doses with median NRS 2.83 ± 2.18. The number of
patients reporting postoperative nausea or vomiting (PONV) were 1 of 18 patients in the
methadone group, 6 of 19 patients in the morphine group and 9 of 18 in the control
group.
A CONSORT flow diagram (Appendix H-2) was used to report data regarding
sample selection, allocation and attrition. The researchers did not report the initial
number of participants assessed for the study. Although the researchers did mention
patients that were intubated longer than 24 hours in the postoperative period were
excluded from the study, it did not report the number of participants that were excluded
for this reason. A total of 55 patients were included in the study.
Murphy et al. (2015) conducted a randomized control trial of patients undergoing
elective cardiac surgery with cardiopulmonary bypass that were randomized to receive
intravenous methadone or fentanyl intraoperatively. The study included 156 patients, age
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ranges 54-75, both groups with a higher percentage of male participants. Height and
weight of each group was within a similar range, and ASA scores were III-IV. Four
options for surgery existed: coronary artery bypass graft (CABG), valve surgery, CABG
with valve surgery or atrial septal defect repair. The induction and maintenance of
anesthesia was treated the same regardless of surgery performed.
Patients were randomized by a computer-generated randomization code to receive
either methadone or fentanyl intraoperatively. The study opioid was prepared by the
operating room pharmacy in identical appearing clear plastic bags, and doses were
reported as equipotent. Induction of anesthesia was induced with midazolam 2-4 mg,
propofol 20-100 mg titrated to loss of consciousness, and rocuronium 0.6-0.8 mg/kg. At
the time of the induction, one half of the study drug was administered via an infusion
pump over 5 minutes. The remainder of the drug, methadone 0.15 mg/kg or fentanyl 6
mcg/kg, was infused over the following two hours. Maintenance of anesthesia was with
sevoflurane 0.4-3%, titrated to Bispectral Index values of 40-60 and to mean arterial
pressure within 20% of baseline value. During rewarming phase of the surgery,
midazolam 5 mg was administered, and during chest closure an infusion of propofol 1050 mcg/kg/min was started and continued until ventilatory weaning in the ICU. Time of
ventilatory weaning in the ICU was comparable of both groups, methadone group at
mean of 4.75 hours and fentanyl group of 4.5 hours. Extubation time was 6.5 and 6.0
hours, respectively. The study did note that the methadone group did have a quicker ICU
discharge to the surgical ward, a mean of 30.5 hours, versus the fentanyl group at 47.1
hours.
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Patients were assessed for pain at rest and with coughing by nurses in the ICU
after discontinuation of the propofol infusion and extubation, and then every 2 hours
after. If pain was reported of higher than mild severity, morphine 2 mg was administered,
with additional doses until patient reported a verbal pain score less than 3. Oral pain
management was transitioned once the patient was discharged from the ICU to the
surgical ward, which consisted of one hydrocodone-acetaminophen 10/325 mg tab for
mild pain, and two tabs for moderate pain. Once on the surgical ward, patients’ pain
scores were evaluated every four to six hours and morphine or oral pain management was
administered as needed.
In the initial 15 minutes in recovery, patients in the methadone group reported a
median pain score of 3, versus the fentanyl group at 5 (p value <0.001). At two hours, the
methadone group reported a median of 3 at rest and 4 with coughing, and the fentanyl
group reported median of 4.5 and 7, respectively (p < 0.001). At 12 hours, the methadone
group reported pain score median of 2, 4 with coughing, and in the fentanyl group, 4 and
6 respectively. Median pain scores at 24, 48 and 72 hours at rest in the methadone group
was 2 for each time, and with coughing: 5 at 24 hours and 4 at 48 and 72 hours. As
comparison, in the fentanyl group, the median scores at rest were 4 at 24 hours and 3, at
48 and 72 hours, and with coughing 7 at 24 hours, 6 at 48 hours and 5 at 72 hours.
Overall satisfaction of pain management was also collected at these times using the VAS
and ranged from 90-100 in the methadone group, and in the fentanyl group ranged from
70-90.
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Opioid related complications were reported as nausea, vomiting, itching,
hypoventilation, hypoxemia and sedation. In the methadone group, nausea was reported
in 50%, vomiting 24%, itching 22%, hypoventilation 4%, hypoxemia 13% and sedation
83%. In the fentanyl group, nausea was reported in 56%, vomiting 19%, itching 12%,
hypoventilation 4%, hypoxemia 8% and sedation 90%.
Murphy et al. (2015) reported decreased morphine requirements in the first 24
hours after cardiac surgery and improved pain scores 12 hours after extubation,
summarized in median and interquartile ranges. These variables were compared between
both randomized groups utilizing the Mann-Whitney U test and median differences and
their 99% Cis were calculated. Murphy et al. (2015), concluded that intravenous
morphine requirements during the first 24 hours after surgery and total doses of
postoperative morphine were reduced by 40% in the methadone group. They reported
that nearly one third of the patients in the fentanyl group required high dose morphine,
defined by greater than 20 mg, for pain control in the first 24 hours. This was compared
to the 2.5% of patients in the methadone group that required high dose morphine in the
postoperative period. Additionally, the five patients that did not require morphine 24
hours postoperatively were all from the methadone group.
A few limitations were noted within the study conducted by Murphy et al. (2015).
Although a safe and effective dose of methadone was used intraoperatively for the
purpose of this study, the most optimal methadone dose was not determined.
Additionally, the pain scale was only reported until 72 hours postoperative, and high risk
cardiac patients were excluded from enrollment of the study.
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The study conducted by Murphy et al. (2015) reported participant inclusion and
exclusion criteria, and the number of patients assessed for the study. A CONSORT chart
(Appendix H-3) was created to evaluate the sample selection, allocation and attrition of
the study. Eight patients were excluded before completion of the ICU data collection due
to protocol violations, study drug unavailable at start of surgery, canceled surgery due to
calcified aorta, and patient death after ICU arrival. A large sample size of 156
participants completed the study and were included in the final analysis.
Thoracic Surgery
Matot, Drenger, Weissman, Shauli and Gozal (2004) conducted a study using
clonidine, bupivacaine and methadone as sole analgesics for patients undergoing a
thoracotomy for lung resection. The study evaluated 47 patients undergoing a lung
resection and treated postoperatively for 72 hours with one of the study drugs. One of the
main objectives of this study was to evaluate lung function and evaluated spirometry
throughout the study, along with pain management. For purposes of this systematic
review, pain scores will be the only reported values.
Patients were premedicated with diazepam 10 mg orally, one hour prior to the
procedure. In the operating room, an epidural catheter was placed at either T4-T5 or T5T6 intervertebral space with 4 cm of catheter in the epidural space. A 3 mL test dose of
lidocaine 2% with epinephrine (1:200,000) was administered, followed by 10 mL of
bupivacaine 0.25%. Correct placement of the catheter was confirmed by a sensory loss of
cold sensation above T4. A minimum of 20 minutes elapsed before start of surgery to
allow for achievement of effect. General anesthesia was then induced with Propofol 2
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mg/kg, fentanyl 2 mcg/kg and vecuronium 0.1 mg/kg. Maintenance of anesthesia was
achieved with isoflurane in a 50% oxygen-nitrous oxide mixture. Additional doses of
fentanyl 1.5 mcg/kg were administered when mean arterial pressure or heart rate
increased 25% from the baseline value. Additional boluses of vecuronium were
administered when clinically required.
During skin closure, patients were selected and placed into a double blinded
group to receive one of the three study drugs for postoperative analgesia. Patients in the
clonidine group received an initial dose of clonidine 8 mcg/kg in 10 mL of saline over 20
minutes, followed by an infusion of 1 mcg/kg/hr. Patients in the bupivacaine group
received an initial dose of 10 mL of 0.25% bupivacaine over 20 minutes, followed by an
infusion of 0.125% bupivacaine. Patients in the methadone group received an initial dose
of 6 mg of methadone in 10 mL of normal saline over 20 minutes, followed by an
infusion of 0.5 mg/hr. The maintenance infusion of each group ran during the first 72
hours postoperatively and pain scores were recorded at 8, 24, 48 and 72 hours. On a
numerical pain scale from 0-10, if pain scores were greater than or equal to a 3 at rest, or
4 with coughing, patients were given diclofenac 75 mg, a nonsteroidal anti-inflammatory
drug (NSAID), intramuscularly.
Matot et al. (2004) reported pain scores determined by the NRS were not
statistically significant throughout the study period. The study reported in all groups, pain
was significantly lower at 72 hours compared to those at 8 and 24 hours. By the third day,
the bupivacaine group required more diclofenac than the clonidine or methadone groups
to achieve pain scores lower than 3 at rest or 4 with coughing. The bupivacaine group
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required 575 mg (standard deviation 115), clonidine 325 mg (SD 90) and methadone
group 300 mg (SD 120). The study recorded adverse side effects, including pruritis,
vomiting, hypotension, bradycardia, weakness or numbness of limbs, urinary retention
and sedation. Methadone was the only group in which 3 patients, or 21%, reported
pruritis. Each group reported vomiting, 6% in the clonidine group, 12% in the
bupivacaine group and 28% in the methadone group. Hypotension and bradycardia were
not noted in the methadone group. Hypotension occurred in both 24% of the clonidine
and bupivacaine groups, and bradycardia only occurred in 12% of the clonidine group.
Weakness or numbness of limbs was reported in 12% of the bupivacaine group and in
neither of the methadone or clonidine group. All groups reported urinary retention.
Sedation was reported in 18% of the clonidine group, 0% of the bupivacaine group, and
14% of the methadone group.
The study conducted by Matot et al. (2004) demonstrated pain scores on the NRS
were not statistically significant between the groups throughout the study period. By the
third postoperative day, it was reported the bupivacaine group required slightly more
diclofenac to achieve pain scores less than or equal to 3 at rest, or 4 with coughing. A few
limitations existed within the study. One limitation of the dose of clonidine was selected
based on previous reports of clonidine usage in controlling postoperative pain. The dose
selected for this study was based on previous studies concluding that higher doses caused
excessive patient sedation and hemodynamic instability, which were two variables
studied and reported. The study also lacked a placebo group, and reported on small,
unequal populations within each group.

47

A CONSORT flow diagram was created for this study to collect data reported
regarding sample selection, allocation and attrition rates (Appendix H-4). The study did
not provide information regarding the 7 patients that were excluded due to intraoperative
reasons. There were no participants lost to analysis or follow up after the initial selection
and randomization of treatment groups.
Perez et al. (2007) evaluated epidural methadone for acute post thoracotomy pain
versus ropivacaine with fentanyl. The study was a prospective, randomized, open labeled
clinical trial that compared two epidural analgesic regimens. Patients scheduled for an
elective thoracotomy for lung resection surgery, age range 54-61, ASA II-III. A total of
49 patients over a 4-month period were included in this study.
Preoperative anesthetic management included midazolam (dosage not specified).
Before induction of general anesthesia, an epidural catheter was placed at T8-9
intervertebral space and a test dose of 4 mL of 2% lidocaine with adrenaline was
administered. General anesthesia was induced with propofol, fentanyl, and rocuronium.
Maintenance of anesthesia included propofol, remifentanil and rocuronium. Dosages for
drugs during both phases were not reported. Postoperative analgesia was initiated on
chest closure with 5 mL of ropivacaine 0.5%. Patients were randomized to two groups,
patient controlled epidural analgesia (PCEA) and epidural methadone. The PCEA group
received a continuous infusion of 0.16% ropivacaine plus fentanyl 3.5 mcg at a
continuous rate of 6-10 mL/hr, along with a patient controlled, self-administration dose of
4 mL boluses with a lockout interval of 20 minutes between each bolus. The epidural
methadone group received boluses every 8 hours of 4-6 mg preservative free 0.1%
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methadone, based on a formula including patients weight and age. Both groups received
intravenous ketorolac 30 mg every 8 hours, and rescue analgesia included propacetamol
four times daily when pain at rest was reported equal to, or above a 3 on the NRS.
Epidural analgesia was administered to the PCEA group over 3.3 ± 0.1 days and 3.7 ± 0.2
days in the methadone group.
Pain scores were taken at 1, 2, 6, 12, 24 and 48 hours after the procedure. Initially,
69.6% of the methadone group requested rescue analgesic at 1 hour versus 44% in the
PCEA ropivacaine with fentanyl group. However, patients in the PCEA group requested
more rescue analgesia during the first 24 and 48 hours compared to the methadone group.
At 24 hours, 32% of the PCEA group requested rescue analgesia versus 8.7% in the
methadone group, and at 48 hours, 28% versus 0% respectively, requested rescue
analgesia. Secondary effects, sedation, hypotension, motor blockade, vomiting and
pruritis were recorded for each group. Sedation, hypotension, vomiting and pruritis were
reported at 1 hour and two reports were given for 24 hours, some with different values. In
the methods section, the authors report secondary adverse effects were recorded during
the first 48 hours. It is unclear if the author made a mistake and mislabeled the time
reported in the secondary effects table. No other secondary effects at 48 hours are
reported within the article. The following information is reported as it has been reported
in the study. Sedation scores in the PCEA group were 28% at 1 hour, 0% at 24 hours and
4% at 24 hours in the PCEA group, and 39.1%, 13% and 15% in the methadone group,
respectively. Hypotension ranged from 0-28% through the 1-24 hours in the PCEA
group, and 0-8.7% in the methadone group. Neither group reported a prolonged motor
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blockade during any interval postoperatively. Vomiting in the PCEA group ranged from
0-12% in 1 hour to 24 hours postoperatively versus methadone which sustained 13%
through all periods. Less than 5% of pruritis was reported in the PCEA group and 4.3%
was reported in the methadone at 24 hours, but was not reported during other intervals. A
telephone survey was carried out four months after the procedure to evaluate for chronic
pain. Two patients from the PCEA group reported persistent thoracic pain and 1 from the
methadone group. Researchers concluded a total incidence of 6.1% prevalence of chronic
postoperative chronic pain was found.
The CONSORT flow diagram was used to report sample selection, allocation and
attrition (Appendix H-5). There were no reports of patients excluded from the study or
loss of participants during the study. Limitations included small sample size and
ambiguous data regarding interval of recording. Although drugs were administered via
the same epidural route, they were on different time intervals and patients in the PCEA
group received a continuous infusion and had the option to self-administer a dose when
they felt necessary, versus the methadone group that received bolus dosage every eight
hours.
Cross Study Analysis
The randomized control trials used for this systematic review were analyzed
across studies utilizing data extracted and organized in the data collection sheet
previously shown in Table 2. This tool was used to record and analyze surgery time, time
to extubation, time to first rescue analgesic, NRS score in the first 24 hours, NRS over
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the length of time the study evaluated pain, reported rescue drug use and adverse events
(Appendix I).
Mixed results regarding the efficacy and improvement in pain scores and adverse
reactions to methadone treatment throughout the perioperative period were presented
through cross study analysis of the studies involved in this systematic review. The study
conducted by Murphy et al. (2015) (Appendix I) significant reduction in postoperative
NRS scores and opioid use was noted within the methadone group compared to the
fentanyl group. Initial time to first rescue analgesic dose in the methadone group ranged
from 3.25-9.25 hours, versus the fentanyl group requiring analgesia much sooner, at 1.55.75 hours. Pain scores at rest were significantly less in the methadone group than the
fentanyl group throughout the first 72 hours (P <0.001 to 0.002). Similarly, pain scores
while coughing were less in the methadone group than in the fentanyl group throughout
the first 3 postoperative days (all P < 0.001). Intravenous morphine requirements in the
methadone group were reduced by 40% during the first 24 hours postoperatively and
reported a higher patient perceived quality of pain management. Perez et al. (2007)
(Appendix I) found epidural methadone had a reduction in rescue analgesia in the
methadone group versus PCEA ropivacaine with fentanyl group. Although the study
found that rescue analgesia at 1 hour was increased in the methadone group, it was
significantly decreased at 24 and 48 hours. The percentage of patients that requested
doses of rescue analgesia was reported as 8.7% and 0% at 24 and 48 hours in the
methadone group, and in the PCEA group 32% and 28%, respectively (P < 0.05). Matot
et al. (2004) reported a significant difference (P < 0.05) in pain scores among participants
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that received clonidine, bupivacaine and methadone for postoperative thoracotomy pain.
The study reported little significance between the three drugs but did note the participants
in the bupivacaine needed significantly more rescue analgesia to achieve lower scores
when compared to the clonidine and methadone groups.
Lastly, in the two studies by Carvalho et al. (2011) and Udelsmann et al. (2011)
both compared methadone to morphine and found methadone superior in the
management of postoperative pain relief. Carvalho reported a methadone efficacy 22%
higher than that of morphine, with pain scores lower at 12 and 24 hours postoperative,
(p= 0.186) and (p= 0.029). Udelsmann reported the first dose of analgesic in the
methadone group was requested after a longer period of time (p = 0.0261). In addition,
the number of patients that required analgesics was significantly lower in the methadone
group (p = 0.025) and the quality of analgesia was improved in the methadone group (p <
0.01).
Adverse events reported among all of the studies included nausea, vomiting,
respiratory failure, sedation, hypotension, bradycardia, pruritis, hypoventilation, and
hypoxemia. Nausea and/or vomiting or described as postoperative nausea and vomiting
(PONV), were among the most common side effects throughout all studies in both the
methadone and intervention groups. Data regarding these side effects were similar across
all studies comparing methadone to other opioids such as morphine and fentanyl.
Udelsmann (2011) did show the incidence of PONV was significantly lower than in the
methadone group versus the other two groups (p= 0.013).
Next, summary and conclusions section will be presented.

52

Summary and Conclusions
Pain plays a significant role of the perioperative period and is much anticipated
after surgery. Patients often express postoperative pain as a major concern, with
uncontrolled pain being a primary fear (Hutchinson, 2007). As a result, postoperative
pain control is a primary goal for patients and providers. Persistent acute pain is
associated with increased risk of morbidity, impairment of functionality and quality of
life, delays in recovery, increased financial burden and prolonged opioid usage (Gan,
2017). Health risks such as impaired mobilization, deep vein thrombosis, pneumonia,
respiratory failure, pulmonary embolism and wound infections can further spiral into
negative consequences that can relate to increased morbidity and mortality (Hutchinson,
2007). Furthermore, prolonged acute pain can lead to the development of chronic pain,
which can contribute to disability, depression, reduced quality of life, morbidity and
mortality (Gan, 2017). Management of pain throughout the perioperative period is crucial
to successful management of the surgical patient. The purpose of this paper is to conduct
a systematic review to determine if intraoperative methadone administration will affect
postoperative pain after cardiothoracic and thoracic surgery as evidenced by pain score
levels and documented postoperative opioid use.
A literature review was conducted utilizing a table with inclusion and exclusion
criteria created by the author. The PRISMA checklist (Appendix A) was used to review
each article prior to selection. The PRISMA flow diagram was then used to assist in the
organization and collection of data from the literature search (Appendix F). A total of
five randomized control trials were selected. The randomized control trials were further
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critiqued using the CONSORT checklist (Appendix B) to evaluate strength and
significance of the studies discussed in this systematic review. Data was collected from
each of the articles and information was recorded within tables created by the author
(Appendix C). Information drawn from each study included author, publication year,
number of patients in the trial, age of participants, gender, ASA score, procedure,
duration, methadone group, control group and route of drug administration, agents used
for induction of anesthesia, agents for maintenance of anesthesia, administration time of
study drug, intraoperative dose of methadone, intraoperative control dose, recue pain
dosing, time to first rescue analgesic for methadone group, time to first rescue analgesic
for control group (Appendix G-1, 2). Strengths and weaknesses from each study were
recorded in a separate table created by the author of this review using the criteria
published from the CONSORT checklist (Appendix G-3). With the focus on sample size,
randomization and attrition rates of participants for each randomized control trial, a
PRISMA flow diagram was completed for each study (Appendix H-1, 2, 3, 4, 5).
Analysis across the studies was completed utilizing the chart in Appendix I. This chart
recorded the surgical time, time to extubation, time to first rescue analgesic, the
numerical rating scale (NRS) score in the first day, the NRS score in extended periods,
reported rescue drug use and adverse events.
Three of the studies reported the amount of time that passed until the patient
required their first rescue analgesic in each of the groups. Carvalho et al., (2011) reported
that the rescue dose of analgesia was required sooner in the methadone group than in the
morphine group. (Appendix G-2). Udelsman et al., (2011) and Murphy et al., (2015),
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reported time to first rescue analgesic was much more delayed in the methadone group in
each of their studies versus the control group (Appendix G-2). With the exception of
Matot (2004), which reported no clinical significance between the three drugs studied, the
other four studies showed that the patients in the methadone group reported overall lower
pain scores on the NRS scale in the first 24 hours (Appendix I). Reports of pain scores
later than 24 hours postoperative were not reported in two of the studies. In the trial
conducted by Carvalho et al., (2011), pain scores were similar in both groups at 36 hours
postoperatively. Murphy et al., (2017), reported slight improvement in pain scores in the
methadone group at 72 hours postoperative (Appendix I). Perez et al., (2007), reported no
additional pain management requirements at 48 hours postoperative in the methadone and
28% of patients requesting additional pain management in the ropivacaine plus fentanyl
group (Appendix I).
Adverse effects noted from the drugs were recorded in all five of the studies
presented. The most commonly presented side effect of the drugs were postoperative
nausea and vomiting (PONV). Of the studies that compared other opioids, such as
morphine to methadone, the data regarding PONV was similar. Nausea with vomiting
ranged from 5-28% of patients and was not highly significant based on the opioid the
patient was given. Other side effects reported included pruritis, respiratory failure,
hypoxemia, hypoventilation, sedation, hypotension, bradycardia, urinary retention, and
limb weakness (Appendix I).
Limitations existed in this systematic review. Although studies included in this
review fulfilled the inclusion criteria, the inclusion of five randomized control trials with
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relatively small sample sizes may decrease the generalizability of this study.
Additionally, the review may have been more generalizable if all participants had the
same surgical procedure, same control drug and if the drug was given by the same route
in each study. The rescue drug in two of the trials by Carvalho et al. (2011) and
Udelsmann et al. (2011) used morphine as the control drug and also as the rescue
analgesic. This may have affected the strength of the results.
Diversity varied greatly among the five randomized control trials and may have
contributed to a weakened conclusion of the study. Each study administered the
methadone and control drug at different time intervals during the operation and by
different routes. Some studies administered the drug after induction of anesthesia, while
Murphy et al. (2015) administered half after induction and then the other half over the
following two hours. Carvalho et al. (2011) administered the drug at the end of the
surgery, but did not specify when, while Matot et al. (2004) administered the drug during
skin closure and Perez et al. (2007) administered at the closure of the chest cavity. Four
of the five studies administered the drug intravenously, and one administered the drug via
epidural route. Although each study reported the overall NRS scores in the first 24 hours
after drug administration, some studies failed to record NRS scores further than 24 hours.
This potentially could have weakened the conclusions of the study, as methadone halflife can range greatly among individuals and exert a prolonged effect up to 90 hours
(Barbosa Neto, et al., 2014). Additionally, the studies reported by Matot et al. (2004) and
Perez et al. (2007) did not document the time of the first requested rescue analgesic after
the methadone or control drug was administered (Appendix G-2).
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Due to the many limitations, this systematic review does not provide sufficient
evidence to implicate the use of methadone as an effective means to decrease
postoperative pain after thoracic surgery. Recommendations and implications for
advanced nursing practice will be discussed in the next section.
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Recommendations and Implications for Advanced Nursing Practice
Advanced Practice Registered Nurses (APRNs), including Certified Registered
Nurse Anesthetists (CRNAs) rely on evidence-based research to care for patients.
Systematic reviews are frequently reviewed to evaluate a large sum of information
throughout multiple published studies to present recommendations for best practice. This
supports safe practice and the most up to date knowledge informing the anesthesia
community. CRNAs provide anesthesia to patients undergoing cardiothoracic or thoracic
surgery until the procedure is completed and the patient is transported to their respective
recovery areas and care is designated to the registered nurse in the Post Anesthesia
Recovery Unit (PACU) or Intensive Care Unit (ICU). Treatment of pain throughout a
procedure or surgery is important not only during the procedure, but for the prevention of
pain upon their arrival and stay in the PACU or ICU.
The delivery of anesthesia is often defined as the combination of both science and
art. Ability to provide anesthesia is achieved through extensive training in both classroom
and surgical settings with a focus on the delivery of safe, effective and appropriate
anesthesia. Continued education and reviewing current research is crucial for the
anesthesia provider and the safety of their patients. Systematic reviews, such as this one,
are intended to review multiple research articles and extract information that may be
useful to better serve the surgical population undergoing anesthesia. It allows for CRNAs
to consider the most up to date, safest and most effective methods of providing
anesthesia.
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One of the most important factors in providing an effective anesthesia involves
the treatment of pain. Prevention and treatment of pain is often discussed and disputed
due to the multiple options for pain management. Methadone is often stigmatized due to
its use in opioid addiction treatment programs. It is also often used in the treatment of
chronic pain, especially in patients with cancer. The use of methadone within the
operating room for standard procedures is not widely discussed nor used. The purpose of
this paper is to conduct a systematic review to determine if intraoperative methadone
administration will affect postoperative pain after cardiothoracic and thoracic surgery as
evidenced by pain score levels and documented postoperative opioid use.
The use of methadone during the perioperative phase of cardiothoracic and
thoracic surgery in this systematic review had mixed results. As noted on Appendix I, the
NRS scores were not significantly different across all of the studies in the methadone
group. However, utilizing methadone in the surgeries specific to cardiothoracic, slight
improvements in pain scores were noted. This may present a need for future randomized
control trials to evaluate the use of methadone pertaining specifically to cardiothoracic
surgery. Future studies may be performed comparing methadone and morphine, with the
recommendation of a rescue drug being different than the one utilized as a control drug,
as most of these studies used morphine in the intraoperative and postoperative pain
management. These studies would be essential to evaluate the most effective
management of pain in the population of thoracic surgical patients.
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Appendix A

(Moher et al., 2009)
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Appendix B

(CONSORT, 2010)
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Appendix C
Data Collection Chart #1
Author, Year

#Pt Ages (yr) M/F

ASA Procedure

Duration

methadone

Control

(min)

Group

Group

Route
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Appendix D
Data Collection Chart #2
Author,
Year

Agents for
Induction
of
Anesthesia

Agents for
Admin
Maintenance time of
of Anesthesia study
drug

Intraoperative Intraoperative Rescue
Methadone
Control Dose pain
dose
dosing in
recovery

Time to 1st
rescue
analgesic
(hours)
methadone

Time to 1st
rescue
analgesic
Control group
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Appendix E
Randomized Control Trial Chart
Author,

Study

Consent/ Inclusion

Exclusion Randomization

Year

Type

Funding

Criteria

Criteria

Attrition Blinding

Strengths

Limitations
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Appendix F

Enrollme
nt

PRISMA 2009 Flow Diagram

Records identified
through database
searching
(n = )

Additional records
identified through other
sources

Allocation

(n = )
Records after duplicates removed
(n = )

Follow Up

Records screened
(n = )

Full-text articles
assessed for eligibility
(n = )

Records excluded
(n = )

Full-text articles
excluded, with
reasons
(n = )

Analysis

Studies included in
qualitative synthesis
(n = )

Studies included in
quantitative synthesis
(meta-analysis)
(n = )

(Moher et al., 2009)
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Appendix G-1
Data Collection Chart #1
Author,
Year

#Pt Ages M/F
(yr)

ASA

Procedure

Duration
(min)

Methadone Control Group
Group

Route

a Carvalho, 100 52-73 63/37
2011

III/IV CABG

140-253

n = 50

Morphine n = 50

IV

b Udelsman 55
n,
2011

III-IV Cardiac
Surgery

228-373

n = 18

Morphine n = 19
saline n = 18

NR
(inferred IV)

324-371

n = 77

Fentanyl n = 79

IV

40-72 30/25

c Murphy,
2015

156 54-76 115/4
1

III-IV CABG, Valve,
CABG and
Valve, ASD

d Matot,
2004

47

43-72 29/18

I-III

Lung Resection 92-278

n = 14

Clonidine n = 16
bupivacaine n = 17

Epidural

e Perez,
2007

49

54-61 NR

II-III

Lung Resection 138-210

n = 24

ropivacaine plus
fentanyl n = 25

Bolus/ PCEA

NR= Not Reported
ASA Physical Status Classification System
ASA I: A normal, healthy patient
ASA II: A patient with mild systemic disease
ASA III: A patient with severe systemic disease
ASA IV: A patient with severe systemic disease that is a constant threat to life
ASA V: A moribund patient who is not expected to survive without the operation
ASA VI: A declared brain-dead patient whose organs are being removed for donor purposes
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Appendix G-2
Data Collection Chart #2
Author, Year Agents for
Induction of
Anesthesia

Time to 1st
rescue
analgesic
(hours)
Control group

Admin
time of
study
drug

Intraop
methadone
dose

sufentanil
0.5 mcg/kg,
10 mcg
bolus PRN,
etomidate
0.2mg/kg,
rocuronium
01.mg/kg

sufentanil 0.250.5 mcg/kg/hr,
sevoflurane 0.5-1
MAC

End of
surgery

methadone morphine 0.1 Dipyrone 1 g 2.43 ± 2.98 4.49 ± 4.22
0.1 mg/kg mg/kg
q 6 hours
continuous,

b Udelsmann, sufentanil
2011
0.1mcg/kg,
midazolam,
pancuroniu
m 0.1mg/kg

Sufentanil 0.01
mcg/min,
isoflurane 0.5%
and pancuronium
0.03mg/kg prn

After
inducti
on

methadone morphine 20 morphine
20 mg
mg
0.03 mg/kg
Or
prn
saline 2 mL

c Murphy,
2015

sevoflurane 0.43%**
rocuronium,
midazolam 5mg
during

½ at
inducti
on
½
infused

methadone fentanyl 6
0.15 mg/kg mcg/kg

a Carvalho,
2011

midazolam
4-6 mg PO,
propofol 20100mg*,
rocuronium

Intraoperative Rescue pain
Control Dose dosing in
recovery

Time to 1st
rescue
analgesic
(hours)
methadone

Agents for
Maintenance of
Anesthesia

morphine
0.03 mg/kg
Limit: 0.1
mg/kg in 4h
14.25 ±
9.89 hours

morphine 2 6.5 (3.25mg until pain 9.25)
<3
hydrocodone
/ APAP 1 tab

morphine:
10.43 ± 8.75
saline: 8.46 ±
6.88

3.75 (1.55.75)
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0.608.mg/kg

rewarming,
propofol 1050mcg/kg/min @
closure

over
next 2
hrs

d Matot, 2004 diazepam 10
mg PO,
propofol 2
mg/kg,
fentanyl 2
mcg/kg,
vecuronium
0.1 mg/kg

isoflurane and a
50% oxygen with
nitrous oxide
mixture with
fentanyl 1.5
mcg/kg boluses
prn pain

Skin
closure
at end
of case

e Perez, 2007

propofol, fentanyl
and rocuronium
(doses NR)

Closure methadone ropivacaine
of chest 4-6 mg
0.16% plus
cavity
epidural
fentanyl 3.5
0.1% q 8
mcg CI 6hour bolus 10ml/hr.

midazolam,
propofol,
fentanyl,
rocuronium
(doses NR)

mild pain, 2
tabs for
moderatesevere pain
methadone
6 mg
bolus,
infusion of
0.5 mg/hr

diclofenac
75 mg IM

NR

NR

Scheduled
NR
ketorolac 30
mg q 8 hr.
Rescue:
propacetamo
l 2mg QID

NR

bupivacaine:
0.25% 10
mL bolus,
then 0.125%
infusion of
10 ml/hr

ABW: Adjusted Body Weight
*- titrated to loss of consciousness
**- titrated to BIS monitoring of 40-60 and MAPs within 20% of baseline
CI= Continuous Infusion
NR= Not Reported

clonidine: 8
mcg/kg
bolus with
infusion 1
mcg/kg/hr
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Appendix G-3
Randomized Control Trial Appraisal Chart
Author,
Year

Study
Type

Consent/
Funding

Inclusion
Criteria

Exclusion
Criteria

Randomization Attrition

Blinding

Strengths

Limitations

RCT,
double
blind,
parallel
clinical
trial

Ethics
Committee
approval,
Written
informed
consent

M/F, over
18 years,
ASA III or
IV, CABG
without
Cardiopul
monary
bypass
(CPB)

Illicit drug
use,
allergies to
medications
used, those
remained
intubated
>12 hours
postop

Block
randomized
into two
treatment
groups and
passed to head
of department
to determine
treatment
group

n = 4:
1 death, one
reintubation
and 2
intubated >
12 hours

Patients,
researcher
s and
research
assistants
blinded

Generalizable, no
proportional
difference
between
gender
groups,
methadone
efficacy 22%
higher

Only looked
at first 36
postop hours,
pain is
extremely
subjective, no
standardized
measure for
assessing
level of
sedation

b Udelsmann, RCT,
2011
double
blind
study

Ethics
Committee
approval,
informed
consent

Male,
female, 1480 years
old, ASA
III or IV,
cardiac
surgery
with CPB

Illicit drugs NR
or
antidepressa
nts,
psychiatric
disease,
allergies to
drugs used,
intubation
>24 hours
postoperativ
ely

NR

Anesthesi Generaliza MD and able, no
patient
proportional
difference
between
gender
groups,
Evaluated
number of
patients
requiring
analgesics
and NRS
scores

a Carvalho,
2011

Small sample
size, Poor
description of
methods,
randomizatio
n and
attrition, pain
scores
recorded at
24 hours
postoperative,
no report on
levels of pain
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Author,
Year

Study
Type

Consent/
Funding

Inclusion
Criteria

Exclusion
Criteria

Randomization Attrition

Blinding

Strengths

Limitations

throughout 24
hourspublished as a
mean of pain
score
throughout 24
hour period
c Murphy,
2015

RCT,
double
blind

IRB
approval,
written
informed
consent

Elective
cardiac
surgery
(CABG,
valve,
CABG and
valve, and
atrial
septal
defect
repair)
with CPB
and
extubation
<12 hours
from
surgery

Preop renal
failure
requiring
dialysis,
serum
creatinine
>2.0,
significant
hepatic
dysfunction,
EF <30%,
home O2
therapy,
emergency
surgery,
preoperative
requirement
of
inotropes/I
ABP,
allergy to
drugs in

Computer
generated
randomization
code

n= 8:
3 protocol
violations, 1
canceled
surgery, 1
study drug
unavailable
at time of
surgery, 2
severe HTN
prior to start
of study
drug, 1
death

All
research
team
members
and
nurses

Large
sample size,
double
blinded
Highly
significant
findings:
p <0.001
MannWhitney U
test

Optimal
intraoperative
dose of
methadone
not
determined,
only followed
for 72 hours,
high risk
cardiac
patients were
excluded,
chronic pain
not reported
postop
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Author,
Year

Study
Type

Consent/
Funding

Inclusion
Criteria

Exclusion
Criteria

Randomization Attrition

Blinding

Strengths

Limitations

During skin
closure,
randomly
allocated to a
table of
random
numbers for 1
of 3
postoperative
epidural
analgesia

Double
blinded

Evaluated 3
different
classes of
drugs:
opioid, local
anesthetic
and alpha
agonist

Option for
best analgesic
based
primarily on
PFTs, small
sample size,
limited
information
regarding
pain
management,
evaluated
pain for 72
hours, pain
scores not
reported, not
described
how the study
was blinded,
unequal
intervention
groups

study,
opioid
abuse or
preoperative
opioid use

d Matot, 2004 RCT,
double
blind
prospec
tive
study

IRB
approval,
Written
and
informed
consent

>18 years
old,
elective
thoracotom
y for left
lobectomy

Contraindic
ation to
epidural,
chronic
NSAID use,
allergy to
drugs, lack
of cooperation,
renal or
hepatic
dysfunction,
use of
clonidine,
chronic
opioids or
psychotropi
c drugs,
history of
chronic
pain, resting
HR <50 or
left bundle
branch

n=7
excluded
for
intraoperati
ve reasons
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Author,
Year

Study
Type

Consent/
Funding

Inclusion
Criteria

Exclusion
Criteria

Randomization Attrition

Blinding

Strengths

Limitations

Computer
0
generated
program into 2
groups

Nonblinded
open
study

High degree
of treatment
satisfaction,
48 hour
study with a
4 month
telephone
follow up,
patient
demographic
s
proportional

Non-blinded,
small sample
size, time to
first analgesic
dose not well
described

block or
need for
more
extensive
surgery

e Perez, 2007 Prospec Ethics
tive,
RCT,
open
label
clinical
trial

committee
approval
Informed,
signed
consent

ASA II or
III,
scheduled
elective
thoracotom
y for lung
resection
surgery,
No
contraindic
ations to
epidural,
preoperativ
e FEV1
>1000mL

Contraindic
ations to
epidural
including:
coagulation
impairment
or patient
refusal,
preoperative
FEV1
<1000mL

78

Appendix H-1

Enrollment

Carvalho, A.C., Goulart Sebold, F.J., Garcia Calegari, P.M., Heleno de Oliveria, B., &
Schuelter-Trevisol, F. (2018). Comparison of postoperative analgesia with
methadone versus morphine in cardiac surgery. Revista Brasileira de
Anestesiolgia, 68(2), 122-127.
Patients undergoing Cardiac
Bypass Surgery
(n = 145)

Patients ineligible due
to non-myocardial
revascularization
(n = 32)

Eligible patients
(n = 112)

Excluded for
requiring
cardiopulmonary
bypass
(n =8)

Analysis

Follow Up

Allocation

Randomized (n = 104)

Allocated to morphine
Group

Allocated to methadone
Group

Received allocated
intervention (n= 52)

Received allocated
intervention (n= 52)

Lost to follow up
(n = 2)
1 death, 1 intubation
>12 hours
Discontinued
intervention
(n= 0)

Lost to follow up
(n = 2)
1 reintubation, 1
intubation >12 hours
Discontinued
intervention
(n= 0)

Analyzed (n= 50)

Analyzed (n= 50)

Excluded from analysis:
see above

Excluded from analysis:
see above

Appendix H-2
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Udelsmann, A., Gardini Maciel, F., Servian D.C.M., Reis, E., de Azevedo T.M., Melo
M.D.M. (2011). Methadone and Moprhine during Anesthesia Induction for
Cardiac Surgery. Repercussion in Postoperative Analgesia and Prevalence of
Nausea and Vomiting. Revista Brasileria de Anestesiologia, 61(6), 695-701.
Enrollment

Patients enrolled
(n = 55)

Eligible patients
(n= 55)

Allocated to
methadone Group

Allocated to
morphine Group

Allocated to control
Group

Received allocated
intervention (n= 18)

Received allocated
intervention (n= 19)

Received allocated
intervention (n= 18)

Follow Up

Lost to follow up
(n = 0)
Discontinued
intervention
(n= 0)

Lost to follow up
(n = 0)
Discontinued
intervention
(n= 0)

Lost to follow up
(n = 0)
Discontinued
intervention
(n= 0)

Analysis

Allocation

Randomized (n = 55)

Analyzed (n= 18)
Excluded from
analysis
(n= 0)

Analyzed (n= 19)
Excluded from
analysis
(n= 0)

Analyzed (n= 18)
Excluded from
analysis
(n=0)

Appendix H-3
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Murphy, G.S., Szokol, J.W., Avram, M.J., Greengerg, S.B., Marymont, J.H., Shear, T.,
Parikh, K.N., Patel, S.S., Gupta, D.K. (2015). Intraoperative Methadone for the
Prevention of Postoperative Pain: A Randomized, Double-blinded Clinical Trial
in Cardiac Surgical Patients. Anesthesiology, 122(5), 1112-1122.
Patients ineligible due to:

Enrollment

Patients enrolled
(n = 164)

Protocol violation (n=3)
Surgery canceled (n= 1)
Study drug unavailable
(n= 2)

Eligible patients
(n= 156)

Severe hypertension prior
to start (n= 1)
Patient death (n= 1)
Total (n= 8)

Analysis

Follow Up

Allocation

Randomized (n = 156)

Allocated to methadone
Group

Allocated to fentanyl
Group

Received allocated
intervention (n= 77)

Received allocated
intervention (n= 79)

Lost to follow up
(n = 0)

Lost to follow up
(n = 0)

Discontinued intervention

Discontinued intervention

(n= 0)

(n= 0)

Analyzed (n= 77)

Analyzed (n= 79)

Excluded from analysis

Excluded from analysis

(n= 0)

(n=0)

Appendix H-4
Matot, I., Drenger, B., Weissman, C., Shauli, A., & Gozal, Y. (2004). Epidural clonidine,
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bupivacaine and methadone as the sole analgesic agent after thoracotomy for lung
resection. Anaesthesia, 59, 861-866.
Patients enrolled
(n = 54)

Enrollment

Excluded for intraoperative
reasons
Eligible patients
(n= 47)

Total (n= 7)

Allocation

Allocated to
bupivacaine Group

Allocated to
methadone Group

Received allocated
intervention (n= 16)

Received allocated
intervention (n= 17)

Received allocated
intervention (n= 14)

Lost to follow up
(n = 0)
Discontinued
intervention
(n= 0)

Lost to follow up
(n = 0)
Discontinued
intervention
(n= 0)

Lost to follow up
(n = 0)
Discontinued
intervention
(n= 0)

Analyzed (n= 16)

Analyzed (n= 17)

Analyzed (n= 14)

Excluded from
analysis

Excluded from
analysis

Excluded from
analysis

(n= 0)

(n= 0)

(n=0)

Analysis

Allocated to
clonidine Group

Follow Up

Randomized (n = 47)
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Appendix H-5
Perez, J., Jimenez, M.J., Fita, G., Rovira, I., Catalan, M., Gomar, C. (2007). Epidural
methadone for acute post-thoracotomy pain: An alternative to a ropivacaine plus
fentanyl-based patient-controlled epidural regimen. Acute Pain 9,193-199.
Enrollment

Patients enrolled
(n = 49)

Eligible patients
(n= 49)

Analysis

Follow Up

Allocation

Randomized (n = 49)

Allocated to ropivacaine
plus fentanyl

Allocated to methadone
Group

Received allocated
intervention (n= 25)

Received allocated
intervention (n= 24)

Lost to follow up
(n = 0)
Discontinued
intervention
(n= 0)

Lost to follow up
(n = 0)
Discontinued
intervention
(n= 0)

Analyzed (n= 25)

Analyzed (n= 24)

Excluded from analysis

Excluded from analysis

(n= 0)

(n=0)
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Appendix I
Cross Study Analysis
Author,
Year

a Carvalho,
2011

Surgery
Time
(hours)

Time to
Extubation
(hours)

Time to 1st
rescue
analgesic
(hours)

NRS in first NRS
24 hours
Extended
period

methadone: methadone:
2.48-4.23
0.57-7.69

methadone: methadone: At 36
hours:
2.43 ± 2.98 1.9 ± 2.2

morphine:
2.34-3.9

morphine: morphine:
4.49 ± 4.22 2.9 ± 2.6

morphine:
1.23-6.33

Reported
rescue
drug use

Adverse Events

morphine
use:

Adverse
Effects:
methadone: 16%
methadone: methadone morphine: 19%
0.5 ± 1.2
: 29%
Nausea
morphine:
morphine: methadone: 15%
0.5 ± 1.1
43%
morphine: 19%
Vomiting:
methadone: 5%
morphine: 3%
Respiratory
Failure:
methadone: 2%
morphine: 1%

b Udelsmann, methadone: methadone:
4.75 ± 0.84 7.18 ± 5.07
2011
morphine:
4.77 ± 0.96

morphine:
5.98 ± 2.99

methadone: methadone: Not
0.5 ± 0.71
Applicable
14.25 ±
9.89
morphine:
1.84 ± 1.38

methadone PONV*
: 10/18
methadone: 1/18
needed
rescue
morphine: 6/19
morphine
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Author,
Year

Surgery
Time
(hours)

saline: 5.05
± 1.17

Time to
Extubation
(hours)

saline: 5.69 ±
2.41

Time to 1st
rescue
analgesic
(hours)
morphine:
10.43 ±
8.75

NRS in first NRS
24 hours
Extended
period

Reported
rescue
drug use

Adverse Events

saline: 9/18
saline: 2.39
± 2.18

morphine:
14/19
needed
rescue
morphine

saline: 8.46
± 6.88

saline:
17/18
needed
rescue
morphine
c Murphy,
2015

methadone: methadone:
5.40-7.10
5.0-9.5
fentanyl:
5.52-7.12

fentanyl:
4.75-10.5

methadone: NRS at rest:
methadone:
6.5 (3.252 (1-4)
9.25)
fentanyl: 4
(2-7)
fentanyl:
3.75 (1.5NRS with
5.75)
coughing:
methadone:
4 (3-5)
fentanyl: 7
(5-9)

NRS @ 72
hours at
rest:
methadone:
2 (0-3)
fentanyl: 3
(0-5)

morphine
use in first
24 hours
(mg):

Nausea:
methadone: 50%
fentanyl: 56%

Vomiting:
methadone methadone: 24%
: 6 mg fentanyl: 19%
(4-12)
NRS @ 72
Pruritis:
hours with fentanyl:
methadone: 22%
coughing:
10 mg (6- fentanyl: 12%
methadone: 22)
4 (2-5)
Hypoventilatio
n:
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Author,
Year

Surgery
Time
(hours)

Time to
Extubation
(hours)

Time to 1st
rescue
analgesic
(hours)

NRS in first NRS
24 hours
Extended
period

Reported
rescue
drug use

fentanyl: 5
(3-7)

Adverse Events

methadone: 4%
fentanyl: 4%
Hypoxemia:
methadone: 13%
fentanyl: 8%
Sedation:
methadone: 83%
fentanyl: 90%

d Matot, 2004 methadone: NR
2.47-4.37
clonidine:
1.53-4.63
bupivacain
e:
2.0-4.6

NR

Per NRS,
NR
pain score
was not
statistically
significant
between the
three
groups
throughout
the study
period
By POD 3,
bupivacaine
group
required
more

diclofenac
doses
required
(mg):

Sedation:
methadone: 14%
clonidine: 18%
bupivacaine: 0%
Hypotension:

methadone
methadone: 0%
: 300 ± 120 clonidine: 24%
clonidine:
325 ± 90

bupivacaine: 24%

Vomiting:
methadone: 28%
bupivacain clonidine: 6%
bupivacaine: 12%
e: 575 ±

115

Pruritis:
methadone: 21%
clonidine: 0%
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Author,
Year

Surgery
Time
(hours)

Time to
Extubation
(hours)

Time to 1st
rescue
analgesic
(hours)

NRS in first NRS
24 hours
Extended
period
diclofenac
to achieve
NRS scores
<3 at rest
and <4
while
coughing

Reported
rescue
drug use

Adverse Events

bupivacaine: 0%
Bradycardia:
methadone: 0%
clonidine: 12%
bupivacaine: 0%
Urinary
retention:
methadone: 28%
clonidine: 12%
bupivacaine: 30%
Limb Weakness:
methadone: 0%
clonidine: 0%
bupivacaine: 12%
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Author,
Year

e Perez, 2007

Surgery
Time
(hours)

Time to
Extubation
(hours)

methadone: Extubated at
2.3-3.5
conclusion of
surgery prior
ropivacaine to arrival to
with
PACU/ICU
fentanyl
(PCEA) :
2.48-3.32

Time to 1st
rescue
analgesic
(hours)

NRS in first NRS
24 hours
Extended
period

NR

Requested
rescue
analgesia:

At 48
hours:

Requested
methadone: rescue
8.7%
analgesia:
ropivacaine methadone:
0%
with
fentanyl :
ropivacaine
32%
with
fentanyl :
28%

Reported
rescue
drug use

Adverse Events

Sedation:
methadone:
1 h: 39.1%
24 h: 13%
24 h: 13%
PCEA
1 h: 28%,
24 h: 0%
24 h: 4%
Hypotension
methadone:
1 h: 0
24 h: 8.7%
24 h: 4.3%
PCEA:
1 h: 28%,
24 h: 12%
24 h: 0
Vomiting
methadone:
1 h: 13%
24 h: 13%
24 h: 13%
PCEA:
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Author,
Year

Surgery
Time
(hours)

Time to
Extubation
(hours)

Time to 1st
rescue
analgesic
(hours)

NRS in first NRS
24 hours
Extended
period

Reported
rescue
drug use

Adverse Events

1 h: 12%
24 h: 0%
24 h: 4%
Pruritis
methadone:
1 h 0%
24 h: 4.3%
24 h: 0%
PCEA:
1 h: 0%
24 h: 4%
24 h: 4%

PONV= Postoperative Nausea/Vomiting
NR= Not Reported

